Who should consult before using it
Anti-IGF-1 receptor (IGF-1R) monoclonal antibodies (mAbs) were developed for clinical use in treating advanced stage cancers 22,23,24 , including Ganitumab, which remains under investigation as a combination therapy in clinical trials targeting Rhabdomyosarcoma (NCT03041701) and Ewing Sarcoma (NCT02306161), for which it recently received orphan drug status
Suspected adverse effects from any medicine or unlicensed compound should be reported to the MHRA via the Yellow Card scheme
Formulated to provide energy, focus and diet support in conjunction with a sensible diet, exercise and or physical activity
Many patients choose glutathione treatment for cosmetic enhancement while also benefiting from its broader wellness effects
Boosts nitric oxide levels for improved blood flow and recovery